SILVER SPRING, Md., Sept. 29, 2023 /PRNewswire/ — Today, the U.S. Food and Drug Administration is taking steps to help further accelerate the development of novel drug and biological products for rare diseases. The agency is announcing the opportunity for a limited number of sponsors to…